|
1
|
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
|
Ann Oncol
|
2005
|
3.53
|
|
2
|
[Update S3-guideline "colorectal cancer" 2008].
|
Z Gastroenterol
|
2008
|
1.81
|
|
3
|
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
|
Z Gastroenterol
|
2011
|
1.74
|
|
4
|
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006.
|
Ann Oncol
|
2007
|
1.44
|
|
5
|
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
|
Ann Oncol
|
2013
|
1.43
|
|
6
|
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
|
Support Care Cancer
|
2007
|
1.33
|
|
7
|
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
|
Ann Oncol
|
2009
|
1.26
|
|
8
|
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).
|
Z Gastroenterol
|
2010
|
1.20
|
|
9
|
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy.
|
Br J Cancer
|
2013
|
1.08
|
|
10
|
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.
|
Ann Oncol
|
2008
|
1.02
|
|
11
|
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
|
Br J Cancer
|
2003
|
1.01
|
|
12
|
Pancreatic cancer treatment and research: an international expert panel discussion.
|
Ann Oncol
|
2011
|
1.01
|
|
13
|
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.
|
Ann Oncol
|
2008
|
1.01
|
|
14
|
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial.
|
Br J Cancer
|
2009
|
1.00
|
|
15
|
Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells.
|
Cell Mol Life Sci
|
2009
|
0.97
|
|
16
|
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.
|
Ann Oncol
|
2005
|
0.90
|
|
17
|
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
|
Br J Cancer
|
2004
|
0.89
|
|
18
|
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
|
Bone Marrow Transplant
|
2010
|
0.88
|
|
19
|
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
|
Ann Oncol
|
2005
|
0.86
|
|
20
|
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium.
|
Horm Metab Res
|
2009
|
0.85
|
|
21
|
[S3-guideline conference "Colorectal Cancer" 2004].
|
Dtsch Med Wochenschr
|
2005
|
0.83
|
|
22
|
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
|
Ann Oncol
|
2006
|
0.80
|
|
23
|
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
|
Eur J Cancer
|
2003
|
0.80
|
|
24
|
[Extravasation of chemotherapeutic agents: prevention and therapy].
|
Dtsch Med Wochenschr
|
2005
|
0.79
|
|
25
|
Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
|
Ann Oncol
|
2014
|
0.77
|
|
26
|
[Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience].
|
Z Rheumatol
|
2009
|
0.76
|
|
27
|
(Neo-)adjuvant treatments in colorectal cancer.
|
Ann Oncol
|
2005
|
0.76
|
|
28
|
Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.
|
Eur J Cancer Care (Engl)
|
2009
|
0.76
|
|
29
|
[Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
|
Dtsch Med Wochenschr
|
2006
|
0.75
|
|
30
|
Is there a role of high-dose chemotherapy in lymphoma and solid tumours: the present state of the art.
|
Crit Rev Oncol Hematol
|
2002
|
0.75
|
|
31
|
The integration of targeted agents into systemic therapy of metastatic colorectal cancer.
|
Ann Oncol
|
2006
|
0.75
|
|
32
|
Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting: on the way to a highly specialized AYA unit.
|
Klin Padiatr
|
2013
|
0.75
|
|
33
|
Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa.
|
J Cancer Res Clin Oncol
|
2001
|
0.75
|